The proportion of CD8+ T cells, CD4+ T cells, or NK cells (CD3–/CD56+) was significantly lower in MLiM than in CLiM or PLiM tumour areas (Figures S14A,B and S15A,B). This evidence concerns the gene NCAM1 and neoplasm.